FDA Adverse Event Malfunction Summary report: N

RESOLUTE INTEGRITY RX

MDR report key: 6150990 · Received December 7, 2016

Report

Report Number
9612164-2016-01231
Event Type
Malfunction
Date Received
December 7, 2016
Date of Event
November 2, 2014
Report Date
November 11, 2016
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P110013
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IMAGE REVIEW :THE IMAGES REPRESENT OCT IMAGES OF POST-INTERVENTION AT 1 ,2 AND 3 MONTHS FOLLOW UP POST RESOLUTE INTEGRITY STENT IMPLANTATION. THE IMAGES SHOW LOW SIGNAL INTENSITY. DATE OF EVENT - DATE OF PUBLICATION. HEART VESSELS (2016) 31: 206-211 ''NEOINTIMAL COVERAGE OF ZOTAROLIMUS-ELUTING STENT AT 1, 2, AND 3 MONTHS¿ FOLLOW-UP: AN OPTICAL COHERENCE TOMOGRAPHY STUDY'' DOI 10.1007/S00380-014-0598-0.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

FROM (B)(6) 2012 TO (B)(6) 2014, A TOTAL OF 20 PATIENTS WHO HAD MULTI-VESSEL CORONARY LESION WERE RANDOMIZED TO OBSERVE BY OPTICAL COHERENCE TOMOGRAPHY (OCT) NEOINTIMAL COVERAGE AFTER RESOLUTE INTEGRITY IMPLANTATION. CORONARY ANGIOPLASTY WAS PERFORMED ACCORDING TO STANDARD TECHNIQUES. BEFORE THE 1ST INTERVENTION, ALL PATIENTS WITH ACUTE CORONARY SYNDROME RECEIVED ASPIRIN AND CLOPIDOGREL, AND PATIENTS WITH STABLE ANGINA PECTORIS STARTED RECEIVING DAPT. TARGET LESIONS WERE LOCATED IN THE RIGHT CORONARY, LEFT ANTERIOR DESCENDING AND LEFT CIRCUMFLEX ARTERIES. AFTER THE INTERVENTION, ALL PATIENTS CONTINUED TO RECEIVE DAPT DURING THE ENTIRE STUDY PERIOD. ALL PATIENTS HAD MULTI-VESSEL LESIONS; THEREFORE, STAGED PCI WAS PERFORMED AT MONTHS 1¿3 AFTER THE INDEX PCI WITH R-ZES. TIME-COURSE OCT WAS CONDUCTED CONCURRENTLY WITH STAGED PCI AT MONTHS 1, 2, AND 3 AFTER R-ZES IMPLANTATION TO DETERMINE THE PERCENTAGE OF STENT STRUT COVERAGE. (B)(6) PROCEDURES REVEALED NO SERIOUS COMPLICATIONS DURING OR AFTER THE IMPLANTATION OF R-ZES. OCT IMAGES CONFIRMED MALAPPOSED STENT STRUTS. THROMBUS WAS DETECTED IN 2 STENTS. NO CLINICAL EVENTS WERE OBSERVED IN THE PATIENTS DURING THE STUDY PERIOD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
802090 RESOLUTE INTEGRITY RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 67 YR